Clinical Trial Update: An Open Labeled Pilot Study of Atorvastatin in Systemic Lupus Erythematosus [Phase 2, Phase 3]

View source ↗

Summary

An open-label pilot study of atorvastatin in systemic lupus erythematosus is being conducted in Phase 2 and Phase 3, but the current status is not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Buddhist Tzu Chi General Hospital | Conditions: Systemic Lupus Erythematosus | Phase 2, Phase 3 | Status: UNKNOWN